34 /100
MEDIUM RISK
Score updated May 30, 2026

CMPX — Compass Therapeutics, Inc. Dilution Risk Tracker

Track CMPX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CMPX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
70
💰 Cash Runway
0
📊 Float Risk
27
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

Watch
Minor dilution signals detected
10%
💰 Capital Raise 20%
• Active shelf registration ($400M, 93% of market cap)
🔔 Track CMPX — Get forecast alerts →

💹 Market Data

Market Cap$428.61M
Shares Outstanding180.09M
Float122.69M
Cash$194.69M
Debt$9.79M
Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 102.14M shares
#1 Tang Capital Management, LLC 16.79M shares
#2 Orbimed Advisors LLC. 15.22M shares
#3 Suvretta Capital Management, LLC 14.31M shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest31.02M
Days to Cover4.1
% of Float25.3%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2020
Form 4 INSIDER TRANSACTION Apr 29, 2026
Form 4 INSIDER TRANSACTION Apr 29, 2026
13F-HR BENEFICIAL OWNERSHIP Mar 31, 2026
13F-HR BENEFICIAL OWNERSHIP Mar 31, 2026
Full SEC filing analysis available with free account

📰 Recent News

Track CMPX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CMPX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for CMPX
📊 CMPX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CMPX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.